The UltraSEEK Lung Panel enables study of disease progression and resistance in non-small cell lung cancer. Detects over 70 clinically relevant variants across BRAF, EGFR, ERBB2, KRAS and PIK3CA. Identifies variants at as low as 0.1% variant allele frequency. Uses as little as 10 ng of cfDNA. 1 hour of hands-on time and 8 hours of total time.